# Methylene blue as a new signal tracer for nucleic acid-based lateral flow assay

**Authors:** Jurjaan Onayza Noim, Dhruvi Kakadiya, Stephanie Dang, Nabil Royez, Shruti Ahuja, Krishna Prasad Aryal, Siddharth Tallur, Dylan Ravindran Pillai, Richa Pandey

PMC · DOI: 10.1038/s41598-025-19701-4 · 2025-10-14

## TL;DR

This paper introduces a new lateral flow assay using methylene blue to detect nucleic acids with high sensitivity and specificity.

## Contribution

The novel use of methylene blue as a colorimetric and electrochemical tracer in nucleic acid detection is introduced.

## Key findings

- MebiQue-LFA achieved a detection limit of 0.62 fM in buffer and 43 fM in diluted blood.
- The platform showed high specificity and worked well in complex biological matrices like plasma and serum.
- The assay is cost-effective, rapid, and compatible with mobile readout platforms.

## Abstract

We report the development of MebiQue-LFA, a nucleic acid-integrated lateral flow assay that utilizes methylene blue (MB) as a new colorimetric signal tracer for detecting nucleic acids. MebiQue-LFA advances LFA technology by enabling visual detection via blue dye and enhancing sensitivity through integrated electrochemical transduction on the same platform. The electrochemical readout provides a sensitive and quantifiable alternative when visual detection is limited at low analyte concentrations. To demonstrate dual-mode detection, the assay was designed to target a model single-stranded DNA sequence, achieving a detection limit (DL) of 0.62 fM and 43 fM (~ 100 copies/µL) in buffer and contrived diluted (50%) blood respectively, with a dynamic range spanning 1 pM to 1 µM. The platform exhibited high specificity, discriminating single-base mismatches and non-complementary sequences. Furthermore, MebiQue-LFA demonstrated robust performance in complex biological matrices, including plasma and serum, achieving a DL of 16 pM (~ 105 copies/µL). The platform is cost-effective (~ 3 CAD per test), rapid (15 min), stable in different storage conditions and compatible with mobile readout platforms, highlighting its potential for decentralized and point-of-care nucleic acid diagnostics.

The online version contains supplementary material available at 10.1038/s41598-025-19701-4.

## Linked entities

- **Chemicals:** methylene blue (PubChem CID 4139)

## Full-text entities

- **Chemicals:** MB (MESH:D008751), MebiQue (-)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12521506/full.md

---
Source: https://tomesphere.com/paper/PMC12521506